23 September 2024
UBS Principal Capital Asia Ltd. has divested its holdings in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd., and Marksans Pharma Ltd. for a total of Rs 480 crore, as per bulk deal data on the NSE. The details of the sales are as follows:
- Concord Biotech Ltd.: UBS sold 7.4 lakh shares, representing a 0.7% stake at Rs 2589.86 each, totaling Rs 191 crore.
- Five-Star Bus Fin Ltd.: UBS offloaded 15.8 lakh shares, representing a 0.54% stake at Rs 804.74 each, totaling Rs 127 crore.
- IIFL Securities Ltd.: UBS put up 17.1 lakh shares for sale, representing a 0.55% stake at Rs 309.84 each, totaling Rs 53 crore.
- Marksans Pharma Ltd.: UBS offered 34.01 lakh shares for sale, representing a 0.75% stake at Rs 317.22 each, totaling Rs 107 crore.
UBS Principal Capital Asia Ltd. has divested its holdings in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd., and Marksans Pharma Ltd. for a total of Rs 480 crore, as per bulk deal data on the NSE. The details of the sales are as follows:
- Concord Biotech Ltd.: UBS sold 7.4 lakh shares, representing a 0.7% stake at Rs 2589.86 each, totaling Rs 191 crore.
- Five-Star Bus Fin Ltd.: UBS offloaded 15.8 lakh shares, representing a 0.54% stake at Rs 804.74 each, totaling Rs 127 crore.
- IIFL Securities Ltd.: UBS put up 17.1 lakh shares for sale, representing a 0.55% stake at Rs 309.84 each, totaling Rs 53 crore.
- Marksans Pharma Ltd.: UBS offered 34.01 lakh shares for sale, representing a 0.75% stake at Rs 317.22 each, totaling Rs 107 crore.
.jpg?w=1200&auto=format%2Ccompress&ogImage=true)
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.